NCT06092203 (Elattar) is a clinical trial in Pediatric ALL, sponsored by Mansoura University.

Who is sponsoring NCT06092203?

NCT06092203 is sponsored by Mansoura University.

What condition does NCT06092203 study?

NCT06092203 studies Pediatric ALL.

Is NCT06092203 still recruiting?

NCT06092203 is currently status unknown. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT06092203: Elattar

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality of Life for Pediatric Urolithiasis

Status unknown Last updated 23 October 2023

What this trial tests

trial in Pediatric ALL in 100 participants. Status unknown.

Timeline

1 February 2023

Primary endpoint
1 August 2024

1 October 2024

Quick facts

Lead sponsor	Mansoura University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 February 2023
Primary completion	1 August 2024
Estimated completion	1 October 2024
Sites	1 location across Egypt

Conditions studied

Pediatric ALL — all drugs for Pediatric ALL →

Sponsor

Mansoura University

Who can join

Adults 2 to 18, any sex, with Pediatric ALL. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the quality of life (QoL) in pediatric patients with urinary stone disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pediatric ALL

Currently open trials in the same condition.

NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
NCT06867289 — Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring · NA · recruiting
NCT06325280 — Exercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease · recruiting
NCT06274788 — Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Ome · recruiting
NCT06096272 — Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy · NA · recruiting

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06092203 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06092203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing